The expression of the α−2,3 sialyltransferase ST3GAL4 and the O-glycan α−2,6 sialyltransferase ST6GALNAC2 were significantly elevated in the severe COVID-19 cohort (Fig. 3A). The gene discussed is ST3GAL4; the disease is COVID-19.